Farallon Capital Management’s Inspire Medical Systems INSP Stock Holding History

Farallon Capital Management’s Portfolio INSP Stock Details INSP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-626,854	Closed	-$135M	–	180
2024 Q1	$135M	Sell	626,854 -228,242	-27%	-$44.7M	0.57%	41
2023 Q4	$174M	Buy	855,096 +429,000	+101%	+$69.5M	0.8%	36
2023 Q3	$84.6M	Buy	426,096 +103,000	+32%	+$26M	0.39%	47
2023 Q2	$105M	Buy	323,096 +80,500	+33%	+$23M	0.53%	48
2023 Q1	$56.8M	Hold	242,596	–	–	0.31%	58
2022 Q4	$61.1M	Sell	242,596 -239,400	-50%	-$51M	0.36%	59
2022 Q3	$85.5M	Buy	481,996 +68,996	+17%	+$13.9M	0.47%	56
2022 Q2	$75.4M	Buy	413,000 +129,500	+46%	+$25.8M	0.41%	62
2022 Q1	$72.8M	Buy	+283,500	New	+$64.8M	0.35%	60

Other funds holding INSP

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Farallon Capital Management's INSP Position: Q2 2024 in Review

Farallon Capital Management sold out of Inspire Medical Systems (INSP) in Q2 2024, closing a stake of 626,854 shares — an estimated $135M sold.

Farallon Capital Management first reported a position in INSP in Q1 2022 and held it in 9 quarters. The position peaked at $174M in Q4 2023. 325 funds tracked by Wall St. Rank hold INSP as of Q2 2024.

Farallon Capital Management reported no remaining Inspire Medical Systems position as of Q2 2024 after selling out during the quarter.
Farallon Capital Management sold 626,854 Inspire Medical Systems shares in Q2 2024, an estimated $135M.
Farallon Capital Management first reported a position in Inspire Medical Systems in Q1 2022 and held it in 9 quarters.
Farallon Capital Management's Inspire Medical Systems position peaked at $174M in Q4 2023.
325 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q2 2024.

Based on Farallon Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.